094 - Extended Female Cancer Panel (6 tests)

Cancer Panel, Female Extended (AFP, B-HCG Qual., CEA, CA 15-3, CA 19-9, CA 125)

PROVIDER INITIATED TEST - The Extended Female Cancer Panel is a blood test that includes six tumor markers and related tests used to support the evaluation and monitoring of certain gynecologic, breast, and gastrointestinal cancers. These markers are primarily used to assess treatment response, monitor disease progression, or detect recurrence in individuals with a known cancer diagnosis, rather than for routine cancer screening. Because tumor marker levels may also be affected by non-cancerous conditions, results are interpreted in combination with clinical findings, imaging studies, and other diagnostic information. The panel includes 6 tests: CA 15-3: Commonly used to monitor breast cancer CA 19-9: Associated with gastrointestinal and pancreatic cancers CA 125: Commonly used in the evaluation and monitoring of ovarian cancer AFP (Alpha-Fetoprotein): Used in the evaluation of certain liver and germ cell tumors β-hCG, Qualitative, Serum: Detects the presence of hCG, which may be elevated in certain tumors and pregnancy CEA (Carcinoembryonic Antigen): Used to monitor several types of cancers, including colorectal, pancreatic and breast cancer